Medicare Enrolled
Dr. David Ross, MD
Medical Oncology · Rockledge, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Ross from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ross? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Ross
Dr. David Ross is a medical oncology in Rockledge, FL, with 19 years in practice. Based on federal Medicare data, Dr. Ross performed 114,950 Medicare services across 2,768 unique beneficiaries.
Between the years covered by Open Payments, Dr. Ross received a total of $25,919 from 88 pharmaceutical and/or device companies across 1142 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Ross is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice▲ Top 22% volume in FL$ $25,919 industry payments
Medicare Practice Summary
Medicare Utilization ↗114,950
Medicare services
Top 22% in FL for medical oncology
2,768
Unique beneficiaries
$10
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~6,050 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Injectafer) | 26,250 | $1 | $5 |
| Darbepoetin injection (Aranesp) for anemia | 19,960 | $2 | $21 |
| Anti-nausea injection (fosaprepitant) | 14,700 | $0 | $7 |
| Pembrolizumab injection (Keytruda) | 10,400 | $43 | $147 |
| Denosumab injection (Prolia/Xgeva) | 10,140 | $18 | $70 |
| Oxaliplatin chemotherapy injection | 9,900 | $0 | $36 |
| Paclitaxel chemotherapy injection | 3,728 | $0 | $1 |
| Iron infusion (Monoferric) | 3,200 | $17 | $74 |
| Immune globulin infusion (Octagam) | 2,970 | $33 | $250 |
| Injection, degarelix, 1 mg | 1,800 | $3 | $17 |
| Dexamethasone injection (steroid) | 1,614 | $0 | $3 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,240 | $1 | $122 |
| Complete blood count (CBC) with differential | 1,000 | $8 | $35 |
| Anti-nausea injection (ondansetron/Zofran) | 880 | $0 | $4 |
| Office visit, established patient (20-29 min) | 715 | $67 | $180 |
| Blood draw (venipuncture) | 550 | $8 | $19 |
| Epoetin alfa injection (Retacrit) for anemia | 530 | $6 | $30 |
| Injection, leucovorin calcium, per 50 mg | 516 | $3 | $27 |
| Injection, fluorouracil, 500 mg | 474 | $2 | $14 |
| Administration of chemotherapy into vein, 1 hour or less | 473 | $99 | $686 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 434 | $22 | $152 |
| Drug injection, under skin or into muscle | 426 | $11 | $93 |
| Injection, cisplatin, powder or solution, 10 mg | 327 | $2 | $94 |
| Office visit, established patient (30-39 min) | 268 | $96 | $224 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 220 | $54 | $270 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 211 | $1 | $19 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 210 | $47 | $304 |
| Infusion, normal saline solution , 1000 cc | 190 | $2 | $19 |
| Injection, carboplatin, 50 mg | 183 | $2 | $300 |
| Telephone medical discussion with physician, 21-30 minutes | 145 | $73 | $243 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 141 | $16 | $97 |
| Administration of chemotherapy into vein, each additional hour | 133 | $22 | $156 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 123 | $127 | $3,938 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 114 | $26 | $141 |
| Irrigation of implanted venous access drug delivery device | 104 | $18 | $111 |
| New patient office visit (45-59 min) | 92 | $128 | $420 |
| Infusion into a vein for hydration, each additional hour | 88 | $10 | $73 |
| Administration of additional new drug or substance into vein, 1 hour or less | 82 | $50 | $334 |
| Infusion into a vein for hydration, 31-60 minutes | 77 | $25 | $249 |
| Injection, diphenhydramine hcl, up to 50 mg | 77 | $1 | $7 |
| Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l | 46 | $133 | $986 |
| Injection of additional new drug or substance into vein | 42 | $12 | $105 |
| Infusion, normal saline solution, sterile (500 ml = 1 unit) | 42 | $1 | $19 |
| Telephone medical discussion with physician, 11-20 minutes | 37 | $50 | $168 |
| Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion | 32 | $15 | $91 |
| New patient office visit, complex (60-74 min) | 30 | $172 | $432 |
| Office visit, established patient, complex (40-54 min) | 19 | $133 | $360 |
| Advance care planning consultation, first 30 min | 17 | $66 | $189 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
29.3% high complexity
67.9% medium
2.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$25,919
Total received (2018-2024)
Avg $3,703/year across 7 years
Top 20% in FL for medical oncology
88
Companies
1,142
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$25,779 (99.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$140 (0.5%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$4,496
2023$3,479
2022$4,566
2021$3,903
2020$3,559
2019$3,170
2018$2,746
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$2,368
Janssen Biotech, Inc.
$1,982
PFIZER INC.
$1,750
Novartis Pharmaceuticals Corporation
$1,713
E.R. Squibb & Sons, L.L.C.
$1,591
Seagen Inc.
$1,091
Genentech USA, Inc.
$1,006
Amgen Inc.
$913
Incyte Corporation
$821
Celgene Corporation
$758
GENZYME CORPORATION
$729
Merck Sharp & Dohme LLC
$666
Lilly USA, LLC
$648
Takeda Pharmaceuticals U.S.A., Inc.
$537
Daiichi Sankyo Inc.
$510
Astellas Pharma US Inc
$493
Ipsen Biopharmaceuticals, Inc
$493
Merck Sharp & Dohme Corporation
$493
Regeneron Healthcare Solutions, Inc.
$471
Bayer HealthCare Pharmaceuticals Inc.
$405
GlaxoSmithKline, LLC.
$357
Eisai Inc.
$332
Janssen Scientific Affairs, LLC
$287
Pharmacyclics LLC, An AbbVie Company
$275
Gilead Sciences, Inc.
$265
JAZZ PHARMACEUTICALS INC.
$263
Boehringer Ingelheim Pharmaceuticals, Inc.
$238
Puma Biotechnology, Inc.
$236
AbbVie, Inc.
$200
EMD Serono, Inc.
$182
Karyopharm Therapeutics Inc.
$181
Genmab U.S., Inc.
$158
ABBVIE INC.
$158
Kite Pharma, Inc.
$152
Rigel Pharmaceuticals, Inc.
$146
SERVIER PHARMACEUTICALS LLC
$143
AbbVie Inc.
$142
Alexion Pharmaceuticals, Inc.
$127
Celltrion USA Inc.
$119
ARRAY BIOPHARMA INC
$115
Immunomedics, Inc.
$114
BeiGene USA, Inc.
$109
Pharmacyclics LLC, an AbbVie Company
$106
SOBI, INC
$106
Taiho Oncology, Inc.
$103
Exelixis Inc.
$101
Mirati Therapeutics, Inc.
$98
Pharmacosmos Therapeutics Inc.
$97
EISAI INC.
$88
Deciphera Pharmaceuticals Inc.
$86
Clovis Oncology, Inc.
$82
Agios Pharmaceuticals, Inc.
$77
Coherus Biosciences Inc.
$77
ADC Therapeutics America, Inc.
$75
Myovant Sciences Inc.
$71
PUMA BIOTECHNOLOGY, INC.
$67
Epizyme, Inc.,
$67
G1 Therapeutics, Inc.
$66
Bayer Healthcare Pharmaceuticals Inc.
$64
Jazz Pharmaceuticals Inc.
$55
TESARO, Inc.
$48
TG THERAPEUTICS, INC.
$47
Seattle Genetics, Inc.
$43
TOLMAR Pharmaceuticals, Inc.
$39
Acceleron Pharma, Inc.
$36
Dova Pharmaceuticals
$35
PharmaEssentia USA Corporation
$33
Global Blood Therapeutics, Inc.
$29
TerSera Therapeutics LLC
$29
Biocon Biologics Inc
$25
Sumitomo Pharma America, Inc.
$24
CTI BioPharma Corp.
$24
Sun Pharmaceutical Industries Inc.
$22
Menarini Silicon Biosystems, Inc.
$22
Fennec Pharmaceuticals, Inc.
$21
Blueprint Medicines Corporation
$21
TAIHO ONCOLOGY, INC.
$21
Foundation Medicine, Inc.
$20
Advanced Accelerator Applications
$20
MorphoSys, US Inc.
$19
AMAG Pharmaceuticals, Inc.
$17
NOVARTIS PHARMACEUTICALS CORPORATION
$17
Iovance Biotherapeutics, Inc.
$16
Stemline Therapeutics Inc.
$16
MACROGENICS, INC.
$14
Sobi, Inc
$14
Azurity Pharmaceuticals, Inc.
$14
Verity Pharmaceuticals Inc.
$13
Top 3 companies account for 23.5% of total payments
Associated products mentioned in payments ›
ABECMA · ADAKVEO · ADCETRIS · AFINITOR · ALIMTA · ALUNBRIG · AYVAKIT · Abraxane · Alecensa · Aliqopa · Amtagvi · Avastin · BAVENCIO · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Blincyto · CABLIVI · CABOMETYX · CALQUENCE · CERDELGA · COSELA · CYRAMZA · Cabometyx · Cellsearch · DARZALEX · DOPTELET · Doptelet · ELAHERE · ELIGARD · ELIQUIS · ELITEK · ELREXFIO · EMPLICITI · ENHERTU · ENJAYMO · EPKINLY · ERBITUX · ERLEADA · EVENITY · Enhertu · Epkinly · Erleada · FERAHEME · FRUZAQLA · Fabhalta · Fulphila · GAZYVA · GILOTRIF · Halaven · Herceptin · IBRANCE · ICLUSIG · IDHIFA · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INQOVI · INREBIC · Imbruvica · JAKAFI · JAYPIRCA · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · Kadcyla · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · Lunsumio · Lutathera · MARGENZA · MEKINIST · MONJUVI · MONOFERRIC · Mavenclad · Monoferric · NERLYNX · NINLARO · Nerlynx · Neulasta · Nplate · Nubeqa · OJJAARA · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · OXBRYTA · Onivyde · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · PROMACTA · PYRUKYND · Padcev · Pedmark · Perjeta · Phesgo · Pomalyst · Prolia · QINLOCK · REBLOZYL · RETEVMO · RYBREVANT · Reblozyl · Revlimid · Rezlidhia · Rituxan Hycela · Rubraca · SARCLISA · SCEMBLIX · SHINGRIX · SOLIRIS · SOMATULINE DEPOT · SPRYCEL · SUTENT · Somatuline Depot · Stivarga · TAGRISSO · TALVEY · TALZENNA · TASIGNA · TAZVERIK · TECENTRIQ · TECVAYLI · TIBSOVO · TIVDAK · TUKYSA · Tavalisse · Tazverik · Tecentriq · Tecentriq Hybreza · Trelstar · Trodelvy · UKONIQ · ULTOMIRIS · Udenyca · Ultomiris · VEGZELMA · VENCLEXTA · VERZENIO · VIVIMUSTA · VONJO · VOTRIENT · Vanflyta · Vectibix · Venclexta · Veozah · Vitrakvi · Vonjo · Voranigo · Vyloy · XALKORI · XGEVA · XOSPATA · XPOVIO · XTANDI · Xofigo · Xospata · Xtandi · YONSA · Yescarta · ZEJULA · ZEPZELCA · ZYTIGA · Zoladex
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $23 per 100 Medicare services performed
Geographic Context
Medical Oncologys within 10 mi
6
Per 100K population
1.0
County median income
$75,817
Nearest hospital
ORLANDO HEALTH ROCKLEDGE HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Ross is a mixed practice specialist, with above-average Medicare volume (top 22% in FL), and high industry engagement (low-engagement, top 20%), with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Ross experienced with iron infusion (injectafer)?
Based on Medicare claims data, Dr. Ross performed 26,250 iron infusion (injectafer) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Ross receive payments from pharmaceutical companies?
Yes. Dr. Ross received a total of $25,919 from 88 companies across 1,142 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ross's costs compare to other medical oncologys in Rockledge?
Dr. Ross's average Medicare payment per service is $10. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ross) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Medical Oncologys in Rockledge
Browse medical oncologys in Rockledge ranked by procedure volume and transparency data.
Highest volume
Top Medical Oncologys in FL
Medical Oncologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Medical Oncologys in FL
Which FL medical oncologys receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc..
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology